Colgate director granted shares and stock options
COLGATE PALMOLIVE CO director Kimberly A. Nelson received new equity compensation awards.
Rhea-AI Filing Summary
COLGATE PALMOLIVE CO director Kimberly A. Nelson received new equity compensation awards. On May 11, 2026, she acquired 2,075 shares of Common Stock as an annual director stock grant under the issuer's incentive compensation plan, increasing her direct holdings to 11,634 shares.
On the same date, she also received a stock option for 2,424 shares of Common Stock with an exercise price of $86.74 per share, expiring on May 11, 2034. This option becomes exercisable in equal annual installments over three years, beginning on the first anniversary of the grant date. The filing also lists additional indirect holdings through a trust, spouse, and a family trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 4,499 shares
Grant/Award
5 txns
Insider
Nelson Kimberly A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,424 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 2,075 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,424 contracts (Direct);
Common Stock — 11,634 shares (Direct);
Common Stock — 575 shares (Indirect, By Family Trust);
Common Stock — 215 shares (Indirect, By Spouse);
Common Stock — 1,799 shares (Indirect, By Trust)
Footnotes (3)
- F1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.
- F2. Annual director stock option grant under the issuer's incentive compensation plan.
- F3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
Key Figures
Director stock grant: 2,075 shares
Direct holdings after grant: 11,634 shares
Stock option size: 2,424 options
+3 more
6 metrics
Director stock grant
2,075 shares
Annual director stock grant of Common Stock on May 11, 2026
Direct holdings after grant
11,634 shares
Common Stock directly owned after the 2,075-share grant
Stock option size
2,424 options
Stock Option (Right to Buy) for underlying Common Stock
Option exercise price
$86.74 per share
Conversion or exercise price of the stock option
Option expiration
May 11, 2034
Expiration date of the 2,424-share stock option grant
Indirect trust holdings
1,799 shares
Common Stock held indirectly by trust after the reported date
Key Terms
Annual director stock grant, incentive compensation plan, stock unit account, Stock Option (Right to Buy), +1 more
5 terms
Annual director stock grant financial
"Annual director stock grant under the issuer's incentive compensation plan"
incentive compensation plan financial
"under the issuer's incentive compensation plan, credited to a stock unit account"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
stock unit account financial
"credited to a stock unit account pursuant to the issuer's incentive compensation plan"
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
exercisable in equal annual installments financial
"Option becomes exercisable in equal annual installments over three years"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Kimberly A. Nelson report in this Colgate-Palmolive (CL) Form 4?
Kimberly A. Nelson reported new equity awards from Colgate-Palmolive. She received 2,075 shares of Common Stock as an annual director stock grant and a stock option for 2,424 shares, both granted under the company’s incentive compensation plan.
What are the key terms of Kimberly A. Nelson’s new Colgate-Palmolive (CL) stock option?
The new option covers 2,424 shares at an exercise price of $86.74. It is a right to buy Common Stock, expires on May 11, 2034, and becomes exercisable in equal annual installments over three years starting on the first anniversary of the grant date.
Are Kimberly A. Nelson’s Colgate-Palmolive (CL) Form 4 transactions open-market buys or compensation awards?
The reported transactions are compensation-related awards, not open-market purchases. The filing classifies them as grants or awards under Colgate-Palmolive’s incentive compensation plan, including an annual director stock grant and an annual director stock option grant.
When do Kimberly A. Nelson’s new Colgate-Palmolive (CL) options become exercisable?
The options vest in three equal annual installments. According to the filing, they become exercisable in equal annual installments over three years, beginning on the first anniversary of the May 11, 2026 grant date, and expire on May 11, 2034.
AI-generated analysis. How Rhea-AI works. Not financial advice.
